Terms ending in 2039
Every in-force patent on Seegene, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,401,546 | Detection of Target Nucleic Acid Sequences by Pto Cleavage and Extension-Dependent Extension Assay In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 11,448,658 | Method and Device for Controlling Detection-Composition Preparation Instrument In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 11,485,998 | Signal Extraction for a Target Nucleic Acid Sequence In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,018,318 | Method and Device for Analyzing Target Analyte in Sample In force · High confidence | Seegene, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.